Pharma Foods International Co Ltd
TSE:2929

Watchlist Manager
Pharma Foods International Co Ltd Logo
Pharma Foods International Co Ltd
TSE:2929
Watchlist
Price: 938 JPY 1.3%
Market Cap: 26.3B JPY
Have any thoughts about
Pharma Foods International Co Ltd?
Write Note

Pharma Foods International Co Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Pharma Foods International Co Ltd
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Pharma Foods International Co Ltd
TSE:2929
Total Equity
ÂĄ11.5B
CAGR 3-Years
9%
CAGR 5-Years
27%
CAGR 10-Years
13%
GNI Group Ltd
TSE:2160
Total Equity
ÂĄ33.1B
CAGR 3-Years
21%
CAGR 5-Years
25%
CAGR 10-Years
22%
PeptiDream Inc
TSE:4587
Total Equity
ÂĄ58.5B
CAGR 3-Years
33%
CAGR 5-Years
28%
CAGR 10-Years
26%
Takara Bio Inc
TSE:4974
Total Equity
ÂĄ115.8B
CAGR 3-Years
11%
CAGR 5-Years
12%
CAGR 10-Years
7%
S
StemRIM Inc
TSE:4599
Total Equity
ÂĄ8.9B
CAGR 3-Years
-6%
CAGR 5-Years
28%
CAGR 10-Years
N/A
C
Cuorips Inc
TSE:4894
Total Equity
ÂĄ6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Pharma Foods International Co Ltd
Glance View

Market Cap
26.3B JPY
Industry
Biotechnology

Pharma Foods International Co., Ltd. engages in the development and sale of functional food materials. The company is headquartered in Kyoto, Kyoto-Fu and currently employs 293 full-time employees. The company went IPO on 2006-06-12. The firm operates through three business segments. The Mail Order segment is engaged in the sale of supplement Tamagosamin, cosmetics Pearl Skin Lanchel and Derma QII Mild Peeling Gel, through advertising media such as televisions and radios. The Functional Materials segment is engaged in the development and sale of functional materials such as GABA, Bonepep, Folic Acid eggs and Chicken Egg Antibody. The firm is also engaged in the planning and sale of original equipment manufacturer (OEM) products such as supplements and beverages. The Biomedical segment is engaged in the antibody contract manufacture business for drug discovery and diagnostics, and life science information (LSI) business for analysis and efficacy evaluation test of materials and products.

Intrinsic Value
2 599.9 JPY
Undervaluation 64%
Intrinsic Value
Price

See Also

What is Pharma Foods International Co Ltd's Total Equity?
Total Equity
11.5B JPY

Based on the financial report for Oct 31, 2024, Pharma Foods International Co Ltd's Total Equity amounts to 11.5B JPY.

What is Pharma Foods International Co Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
13%

Over the last year, the Total Equity growth was 18%. The average annual Total Equity growth rates for Pharma Foods International Co Ltd have been 9% over the past three years , 27% over the past five years , and 13% over the past ten years .

Back to Top